• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results.局部进展期胃癌腹腔镜手术方法的全国性验证:随机对照试验与真实世界实践结果的比较。
Chin J Cancer Res. 2024 Dec 30;36(6):742-751. doi: 10.21147/j.issn.1000-9604.2024.06.11.
2
Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial.腹腔镜与开腹远端胃癌根治术治疗局部进展期胃癌的 5 年疗效:KLASS-02 随机临床试验结果
JAMA Surg. 2022 Oct 1;157(10):879-886. doi: 10.1001/jamasurg.2022.2749.
3
[Clinical trials of laparoscopic gastric cancer surgery in South Korea: review and prospect].[韩国腹腔镜胃癌手术的临床试验:综述与展望]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):154-159.
4
Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.腹腔镜辅助进展期胃癌根治术的长期疗效:KLASS-02 RCT 随机临床试验。
J Clin Oncol. 2020 Oct 1;38(28):3304-3313. doi: 10.1200/JCO.20.01210. Epub 2020 Aug 20.
5
Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial.腹腔镜远端胃切除术与开腹远端胃切除术治疗Ⅰ期胃癌患者的长期生存效果比较:KLASS-01 随机临床试验。
JAMA Oncol. 2019 Apr 1;5(4):506-513. doi: 10.1001/jamaoncol.2018.6727.
6
Real-world Nationwide Outcomes of Minimally Invasive Surgery for Advanced Gastric Cancer Based on Korean Gastric Cancer Association-Led Survey.基于韩国胃癌协会主导调查的晚期胃癌微创手术的真实世界全国性结局
J Gastric Cancer. 2024 Apr;24(2):210-219. doi: 10.5230/jgc.2024.24.e16.
7
A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).一项多中心前瞻性随机对照临床试验(III 期)比较腹腔镜辅助远端胃癌根治术与全腹腔镜远端胃癌根治术治疗胃癌患者生活质量的差异(研究方案)。
BMC Cancer. 2019 Mar 7;19(1):206. doi: 10.1186/s12885-019-5396-8.
8
Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial.腹腔镜D2淋巴结清扫术式全胃切除术治疗局部进展期胃癌的疗效:KLASS-02多中心随机对照临床试验方案
BMC Cancer. 2015 May 5;15:355. doi: 10.1186/s12885-015-1365-z.
9
Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).腹腔镜与开腹胃癌根治术治疗局部进展期胃癌的多中心随机对照研究(KLASS-02-RCT)的短期疗效观察。
Ann Surg. 2019 Dec;270(6):983-991. doi: 10.1097/SLA.0000000000003217.
10
Laparoscopic vs. Open Gastrectomy for Locally Advanced Gastric Cancer: A Propensity Score-Matched Retrospective Case-Control Study.腹腔镜与开腹胃癌根治术治疗局部进展期胃癌的疗效比较:一项倾向评分匹配的回顾性病例对照研究。
Curr Oncol. 2022 Mar 9;29(3):1840-1865. doi: 10.3390/curroncol29030151.

本文引用的文献

1
Real-world Nationwide Outcomes of Minimally Invasive Surgery for Advanced Gastric Cancer Based on Korean Gastric Cancer Association-Led Survey.基于韩国胃癌协会主导调查的晚期胃癌微创手术的真实世界全国性结局
J Gastric Cancer. 2024 Apr;24(2):210-219. doi: 10.5230/jgc.2024.24.e16.
2
Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer: The JLSSG0901 Randomized Clinical Trial.腹腔镜辅助与开腹远端胃癌根治术治疗进展期胃癌的 5 年生存结局:JLSSG0901 随机临床试验。
JAMA Surg. 2023 May 1;158(5):445-454. doi: 10.1001/jamasurg.2023.0096.
3
Is No. 12a Lymph Node Dissection Compliance Necessary in Patients Who Undergo D2 Gastrectomy for Gastric Adenocarcinomas? A Population-Based Retrospective Propensity Score Matching Study.对于接受胃腺癌D2胃切除术的患者,是否有必要进行第12a组淋巴结清扫?一项基于人群的回顾性倾向评分匹配研究。
Cancers (Basel). 2023 Jan 25;15(3):749. doi: 10.3390/cancers15030749.
4
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.《2022年韩国胃癌诊疗指南:基于证据的多学科方法》
J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11.
5
Overall Survival Advantage of Omentum Preservation Over Omentectomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.保留大网膜与大网膜切除术治疗进展期胃癌的总生存优势:系统评价和荟萃分析。
World J Surg. 2022 Aug;46(8):1952-1961. doi: 10.1007/s00268-022-06562-5. Epub 2022 Apr 24.
6
Survival impact of compliance in extra-perigastric lymphadenectomy for gastric cancer: 20 years of real-world data from a single institution.胃周淋巴结清扫术治疗胃癌的依从性对生存的影响:单中心 20 年真实世界数据。
Surgery. 2022 Apr;171(4):948-954. doi: 10.1016/j.surg.2021.09.017. Epub 2022 Jan 31.
7
Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019.韩国胃癌协会主导的2019年全国手术治疗胃癌调查。
J Gastric Cancer. 2021 Sep;21(3):221-235. doi: 10.5230/jgc.2021.21.e27. Epub 2021 Oct 1.
8
Surgeon Quality Control and Standardization of D2 Lymphadenectomy for Gastric Cancer: A Prospective Multicenter Observational Study (KLASS-02-QC).胃癌 D2 淋巴结清扫术的外科医师质量控制和标准化:一项前瞻性多中心观察研究(KLASS-02-QC)。
Ann Surg. 2021 Feb 1;273(2):315-324. doi: 10.1097/SLA.0000000000003883.
9
Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.腹腔镜辅助进展期胃癌根治术的长期疗效:KLASS-02 RCT 随机临床试验。
J Clin Oncol. 2020 Oct 1;38(28):3304-3313. doi: 10.1200/JCO.20.01210. Epub 2020 Aug 20.
10
Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).一项评价保留大网膜的胃癌根治术治疗进展期胃癌的随机对照 III 期临床试验(JCOG1711,ROAD-GC)。
Jpn J Clin Oncol. 2020 Oct 22;50(11):1321-1324. doi: 10.1093/jjco/hyaa113.

局部进展期胃癌腹腔镜手术方法的全国性验证:随机对照试验与真实世界实践结果的比较。

National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results.

作者信息

Eom Bang Wool, Han Mira, Yoon Hong Man, Hyung Woo Jin, Yang Han-Kwang, Park Young-Kyu, Lee Hyuk-Joon, An Ji Yeong, Kim Wook, Kim Hyoung-Il, Kim Hyung-Ho, Ryu Seung Wan, Hur Hoon, Kim Min-Chan, Kong Seong-Ho, Cho Gyu Seok, Kim Jin-Jo, Park Do Joong, Kim Young-Woo, Kim Jong Won, Lee Joo-Ho, Han Sang-Uk, Ryu Keun Won, Of The Korean Gastric Cancer Association The Information Committee

机构信息

Center of Gastric Cancer, National Cancer Center, Goyang 10408, Republic of Korea.

Department of Medical Research Collaborating Center, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul 07061, Republic of Korea.

出版信息

Chin J Cancer Res. 2024 Dec 30;36(6):742-751. doi: 10.21147/j.issn.1000-9604.2024.06.11.

DOI:10.21147/j.issn.1000-9604.2024.06.11
PMID:39802891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724173/
Abstract

OBJECTIVE

The laparoscopic approach for locally advanced gastric cancer has recently been adopted based on the results of several randomized controlled trials (RCTs). However, findings from RCTs have not been examined at the national level. This study aimed to investigate the external validity of the Korean Laparoscopic Gastrointestinal Surgery Study-02 (KLASS-02) trial involving 13 tertiary hospitals, using data from the Korean Gastric Cancer Association (KGCA)-led nationwide survey involving 68 tertiary or general hospitals.

METHODS

Data on patients who underwent laparoscopic or open distal gastrectomy for pathological stage IB-IIIC gastric cancer under the same conditions were collected from the KLASS-02 trial and the KGCA nationwide survey datasets. Surgical outcomes were assessed for each dataset and multivariable analyses were performed to examine the effect of the laparoscopic approach on surgical outcomes.

RESULTS

The laparoscopic group had a lower overall complication rate than the open group in both KLASS-02 and KGCA datasets (16.1% . 23.5% for the KLASS-02 and 12.6% . 19.6% for the KGCA). Moreover, the laparoscopic group had fewer wound problems, and fewer grade II, IIIa, and IV complications than the open group in the KGCA data (0.8% . 3.4%, 5.8% . 10.4%, 2.3% . 3.7%, and 0.5% . 1.4%, respectively), which were not observed in the KLASS-02 data. Multivariable analyses revealed that the laparoscopic approach was not associated with overall complications, but reduced wound problems and more harvested lymph nodes in the KGCA survey data (adjusted odds ratios, 0.19 for wound problems, adjusted β coefficient 4.39 for number of harvested lymph nodes), which were not shown in the KLASS-02 data.

CONCLUSIONS

The safety and feasibility of the laparoscopic approach for locally advanced gastric cancer were validated at a national level. The laparoscopic approach for locally advanced gastric cancer can be implemented in the Republic of Korea.

摘要

目的

基于多项随机对照试验(RCT)的结果,腹腔镜手术治疗局部进展期胃癌的方法最近已被采用。然而,RCT的研究结果尚未在国家层面进行检验。本研究旨在利用韩国胃癌协会(KGCA)牵头的涉及68家三级或综合医院的全国性调查数据,调查涉及13家三级医院的韩国腹腔镜胃肠手术研究-02(KLASS-02)试验的外部有效性。

方法

从KLASS-02试验和KGCA全国性调查数据集中收集在相同条件下接受腹腔镜或开放远端胃癌切除术的病理分期为IB-IIIC期胃癌患者的数据。对每个数据集评估手术结果,并进行多变量分析以检验腹腔镜手术方法对手术结果的影响。

结果

在KLASS-02和KGCA数据集中,腹腔镜组的总体并发症发生率均低于开放组(KLASS-02中为16.1%对23.5%,KGCA中为12.6%对19.6%)。此外,在KGCA数据中,腹腔镜组的伤口问题更少,II级、IIIa级和IV级并发症也比开放组少(分别为0.8%对3.4%、5.8%对10.4%、2.3%对3.7%和0.5%对1.4%),而这些在KLASS-02数据中未观察到。多变量分析显示,腹腔镜手术方法与总体并发症无关,但在KGCA调查数据中减少了伤口问题并增加了获取的淋巴结数量(伤口问题的调整比值比为0.19,获取淋巴结数量的调整β系数为4.39),而这些在KLASS-02数据中未显示。

结论

腹腔镜手术治疗局部进展期胃癌的安全性和可行性在国家层面得到了验证。局部进展期胃癌的腹腔镜手术方法可在韩国实施。